黛力新对COPD住院患者伴焦虑抑郁的疗效观察

-精选财经经济类资料- -最新财经经济资料-感谢阅读- 1 黛力新对 COPD 住院患者伴焦虑抑 郁的疗效观察 【摘要】 目的 观察氟哌噻吨美 利曲辛片（黛力新）对慢性阻塞性肺疾 病（COPD）伴焦虑抑郁住院患者的疗 效。方法 80 例 COPD 伴焦虑抑郁住院 患者， 按照疗法不同分为常规组与观 察组， 每组 40 例。常规组采用常规治 疗， 观察组在常规治疗基础上加用黛 力新治疗， 对比两组临床疗效、治疗 前后的动脉血气指标血氧饱和度 （SpO2） 、血氧分海PaO2） 、动脉 血二氧化碳分压（PaCO2） 、pH和心理 状态评分焦虑自评量表（SAS）及抑郁 自评量表（SDS ）评分。结果 常规组 的总有效率为 67.5%， 观察组的总有 -精选财经经济类资料- -最新财经经济资料-感谢阅读- 2 效率为 90.0%；观察组总有效率高于常 规组， 差异有统计学意义（P0.05） ； 治疗后观察组 SpO2、PaO2、pH 均高于 常规组， PaCO2 低于常规组， 差异有 统计学意义（P0.05 ） ；治疗后观察组 SAS、SDS 评分均低于常规组， 差异 有统计学意义（P 中国论文网 /6/view- 13024066.htm 【关键词】 氟哌噻吨美利曲辛 片；慢性阻塞性肺疾病；焦虑抑郁 DOI：10.14163/ki.11- 5547/r.2018.13.054 【Abstract】 Objective To observe the efficacy of flupentixol and melitracen tablets （Deanxit ） on anxiety and depression in hospitalized chronic obstructive pulmonary disease （COPD） patients. Methods A total of 80 hospitalized COPD patients with anxiety and depression were divided by different treatment methods into -精选财经经济类资料- -最新财经经济资料-感谢阅读- 3 conventional group and observation group， with 40 cases in each group. The conventional group received conventional therapy， and the observation group received Deanxit for treatment on the basis of the conventional group. Comparison were made on clinical efficacy， arterial blood gas index blood oxygen saturation （SpO2） ， blood oxygen partial pressure （PaO2） ， arterial blood carbon dioxide pressure （PaCO2） ， pH， psychological state score self-rating anxiety scale （SAS） and self-rating depression scale （SDS） score before and after treatment between the two groups. Results The conventional group had total effective rate as 67.5%， which was 90.0% in the observation group. The observation group had higher total effective rate than the conventional group， and the difference was statistically significant （P0.05 ）. After -精选财经经济类资料- -最新财经经济资料-感谢阅读- 4 treatment， the observation group had higher SpO2， PaO2， pH than conventional group， and lower PaCO2 than conventional group. Their difference was statistically significant （P0.05）. After treatment， the observation group had lower SAS and SDS score than conventional group， and the difference was statistically significant （P0.05）. Conclusion Deanxit shows remarkable efficacy on hospitalized COPD patients with anxiety and depressi